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Abstract
Background: Malignant peripheral nerve sheath tumor (MPNST) is a kind of rare neurogenic tumor. If associated
with neurofibromatosis type 1, MPNST usually has a higher mortality. The aim of the article is to assess the imaging
characteristics of MPNST and compare them with those of benign peripheral nerve sheath tumor (BPNST) to
characterize this tumor.
Methods: Clinical and imaging data of six cases with MPNST and 28 cases with BPNST in our institution since 2011
were retrospectively reviewed. Thirty-three patients have available MR imaging data, and two patients of MPNST
also accepted CT scan. One patient accepted CT scan only. Location, size, shape, signal or density, boundary, bone
destruction, relation to adjacent nerve, contrast-enhanced features as well as some other signs were assessed and
compared with statistical software. Student’s t test was used for comparison of continuous variables. Fisher’s exact
test was used for analysis of nominal variable. A P value ≤0.05 was considered to be statistically significant.
Results: Differences existed between two groups in tumor size ((7.2 ± 3.3)cm in MPNST vs. (3.8 ± 1.4)cm in BPNST),
unclear margin (4/6 in MPNST vs. 1/28 in BPNST), eccentricity to the nerve (1/6 in MPNST vs. 21/28 in BPNST),
intratumoral lobulation (4/6 in MPNST vs. 2/28 in BPNST), peritumoral edema (3/6 in MPNST vs. 0 in BPNST), and
peripheral enhancement (4/6 in MPNST (three of five MR, one CT) vs. 4/28 in BPNST). Bone destruction was observed in
one MPNST.
Conclusions: MR imaging is a valuable, non-invasive modality for the diagnosis of MPNST. Peripheral enhancement
with non-cystic appearance or remarkable heterogeneous enhancement may be useful for differential diagnosis. Other
imaging features such as large size (over 5 cm in diameter), ill-defined margin, intratumoral lobulation, peritumoral
edema, and adjacent bone destruction are also supportive of MPNST.
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Background
Malignant peripheral nerve sheath tumor (MPNST) is a
kind of highly aggressive neoplasm originated from
Schwann cells. As the name implies, MPNST develops
in the peripheral nerves and scarcely affects the cranial
nerves [1].The total incidence is extremely low, about
0.001 % of the population [2].About 20–30 % of MPNST
are seen in patient with neurofibromatosis type 1(NF-1)
[3], with mortality up to 4.6–13 % [4]. Unresectable be-
cause of adjacency to big vessel or nerve trunk, frequent
recurrence and distant metastasis of this tumor can be
fatal. So, it is of great importance to diagnose MPNST
before surgery, especially in NF-1 patients. Overlapping
in clinical manifestations, distinguishing it from benign
neurogenic tumor is difficult. Imaging modalities play an
irreplaceable role in diagnosing, forming strategy of
treatment as well as following up. X-ray examination has
limitations except that mammography can be used for
tumor in the breast [5]. Ultrasonography is an easy,
cost-effective, and repeatable modality [6] but unsuitable
for deeply located lesion, i.e., in the retroperinum and
spine canal. PET/CT allows for sensitive whole-body
scan for metastasis but lack of specificity. Computed
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tomography is effective in locating the tumor, giving an
initial diagnosis and making plan for surgery. As a
multi-parameter modality, MRI can provide abundant
information on characterizing different components in
tumor, thus is used for further examination. There are
researches by many authors on imaging of MPNST;
however, as its rarity and lack of specificity, imaging
characteristics are not well known, and reports on super-
ficial and retroperitoneal lesion are rare. In this article,
we report imaging findings of six cases with histological




The study was a retrospective analysis of patient data
and requires no additional treatment, so ethical commit-
tee approval was waived. Written informed consents
were obtained from all patients for publication of their
clinical and imaging data. We reviewed 6 cases of
MPNST and 28 cases of BPNST (including 26 cases of
neurofibroma and 2 cases of schwannoma) in our insti-
tution since 2011. There were totally 15 males and 19 fe-
males, ranging in age from 23 to 78 years (52.8 ±
12.9 years in average). Clinical manifestations include
enlarging palpable mass (9/34), pain or discomfort (9/
34), cough (2/34), weakness (1/34), and frequent mictur-
ition (1/34). Twelve BPNSTs were discovered acciden-
tally or through physical examination. Thirty-three
patients have available MR imaging data, and two pa-
tients of MPNST also accepted CT scan. One patient ac-
cepted CT scan only. Two MPNST and two BPNST
patients had neurofibromatosis type 1 at the same time.
One MPNST in the upper arm had history of surgery in
the same location (Table 1).
Magnetic resonance imaging
MR scans were performed on two 3 T units (Signa HDx
and Discovery MR750; General Electric Medical Systems,
Milwaukee, WI, USA). MRI protocol included axial and
coronal fat-saturated T2-weighted images, T1-weighted
images, and post-contrast T1-weighted images. CT scans
were performed with a 64-row scanner (LightSpeed VCT,
General Electric Medical System). All examinations re-
quired contrast (gadopentetic acid salt, Schering, Germany
or Iohexol, Yangtze, China) intravenous administration.
Imaging and statistical analysis
Images were submitted to two experienced radiologists for
review. The radiologists were required to obtain data on
signal or density information. Signal or density characteris-
tics were compared with those of muscle. Radiologists were
also asked to assess location, size, shape, boundary, bone
destruction, relations to adjacent nerve, contrast-enhanced
features as well as some other signs (i.e. target sign, split
fat sign). All data were obtained by consensus agreement.
Statistical analysis was performed with SPSS software
(version 19.0). Student’s t test was used for comparison
of continuous variables, which were expressed in form
of mean and standard deviation values. Fisher’s exact test
was used for analysis of nominal variable. A P value
≤0.05 was considered to be statistically significant.
Results
Locations
In MPNST group, there were six excised tumors in six
patients, involving the knee, upper arm, cheek, waist,
and retroperitoneal area, respectively. Most tumors de-
veloped in the subcutaneous tissue except for two retro-
peritoneal tumors, one of which was eccentric to the
sciatic nerve. No split-fat sign is observed. As for
BPNST group, there were 28 excised lesions in 28 cases,
and mainly involves intermuscular space of the extrem-
ities, neck, and trunk, as well as the paraspinal, retro-
peritoneal region, and orbit. Connection between tumor
and adjacent nerves can be seen in 21 cases (75 %), and
split-fat sign was observed in 9 cases (32.1 %).
Sizes
The average sizes of MPNST (7.2 ± 3.3 cm, range from
4.2 to 13 cm) were larger than that of BPNST (3.8 ±
1.4 cm, range from 1.1 to 6.3 cm).
Table 1 Clinical data of MPNST and BPNST
Characteristic MPNST (n = 6) BPNST (n = 28) P






Upper extremities 1 1
Lower extremities 1 3
Retroperinum 2 2
Head and neck soft tissue 1 3
Orbit 0 2
Trunk 1 1
NF-1 2 2 0.135
Symptom 0.059
Lump 4 5
Pain or discomfort 1 8
Physical examination 0 12
Others 1 3
Former surgery in same site 0 1 0.176
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Shapes
A spindle or ovoid shape was noted in 22 BPNST (78.6 %)
and five malignant tumors (83.3 %).The margin of the tu-
mors tended to be ill-defined in four MPNST (66.7 %)
and one BPNST (3.6 %). Intratumoral lobulation can be
seen in four MPNST (80 %) and two BPNST (7.1 %).
Signal intensity (density) and enhancement
In MPNST group, four of five (80 %) tumors exhibited
hypo-intense on T1-weighted images (T1WI) and hyper-
intense signal on T2-weighted images (T2WI), and only
one tumor demonstrated mixed signal on T1 and T2WI
because of hemorrhage (Fig. 1 A2, A3). Two NF-1 asso-
ciated tumors showed more complex signal on T2WI
than other tumors (Figs. 2 B2, 3 C2). While in BPNST
group, 20 (71.4 %) tumors were hypo-intense on T1WI
and hyper-intense signal on T2WI, 2 (7.2 %) were
mixed-intense signal, and 6 (21.4 %) were iso-intense on
T1WI and hyper-intense signal on T2WI. Homogeneity
of T1WI can be seen in 10 BPNSTs and 4 MPNSTs,
whereas homogeneity of T2WI can only be seen in 1
BPNST. Typical target sign can be observed in five cases
of BPNST but absent in all MPNST cases. Adjacent soft
tissue swelled and exhibited hyper-intense signal on
T2WI only in three cases of MPNST (Fig. 2 B2). On
plain CT scan, density of tumors tended to be similar to
that of the muscle. In a facial MPNST, calcification,
hemorrhage, and adjacent bone erosion can be found
(Fig. 1 A1). Enhancing pattern on CT and MR was much
alike. After contrast administration, MPNST showed
peripheral enhancement (Figs. 1 A4, 4 D2) (three of five
MR, one CT) or irregular enhancement (Fig. 3 C3) (two
of five MR). Peripheral enhancement was seen more
often in MPNST than in BPNST (4 of 28).
Differences between two groups were statistically sig-
nificant in tumor size, margin, eccentricity to the nerve,
peritumoral edema, intratumoral lobulation, and periph-
eral enhancement. No obvious difference existed be-
tween two groups in T1 and T2 signal intense, target
sign, split-fat sign, and cystic change (Table 2).
Table 2 Comparison of imaging manifestations between BPNST and MPNST
BPNST (n = 28) MPNST (n = 6) P value
Mean ± SD average size (cm) 3.8 ± 1.4 7.2 ± 3.3 0.002a
Shape 0.640
Oval or spindle 22 (78.6 %) 5 (83.3 %)
Irregular 6 (21.4 %) 1 (16.7 %)
Margin 0.002a
Ill-defined 1 (3.6 %) 4 (66.7 %)
Well-defined 27 (96.4 %) 2 (33.3 %)
Eccentricity to the nerve 21 (75.0 %) 1 (16.7 %) 0.014a
Sign on MRI (MPNST (n = 5))
Hypo-intense T1 and hyper-intense T2 20 (71.4 %) 4 (80 %) 0.052
Mixed-intense T1 and T2 2 (7.2 %) 1 (20 %) 0.400
Iso-intense T1 and hyper-intense T2 6 (21.4 %) 0 (0 %) 0.340
T1 (homogenous) 10 (53.6 %) 4 (80 %) 0.089
T2 (homogenous) 1 (3.6 %) 0 (0 %) 0.848
Target sign 5 (17.9 %) 0 (0 %) 0.414
Split-fat sign 9 (32.1 %) 0 (0 %) 0.179
Intratumoral lobulation 2 (7.1 %) 4 (66.7 %) 0.004a
Cystic change 14 (50 %) 2 (33.3 %) 0.389
Perilesional edema-like zone 0 (0 %) 3 (50 %) 0.003a
Enhancement
Peripheral with cystic change 4 (14.3 %) 4 (66.7 %) 0.018a
Honeycomb-like 9 (32.1 %) 0 (0 %) 0.132
Central 5 (17.9 %) 0 (0 %) 0.353
Homogeneous 3 (10.7 %) 0 (0 %) 0.547
Irregular 7 (25.0 %) 2 (33.3 %) 0.513
aStatistically significant
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Fig. 1 MPNST in a 65-year-old female. Plain CT scan (A1) shows a slightly hyper-attenuated lesion in the left cheek with slight zygomatic arch
erosion. On MR scan, the tumor demonstrates hypo-intensity on axial T1-weighted (A2) and heterogeneous hyper-intensity on axial T2-weighted
(A3) images. Gadolinium-enhanced T1-weighted images (A4) reveal peripheral enhancement. Note the central hyper-attenuated foci on plain CT
and mixed-intense signal on T2WI, which is likely to be hemorrhage. Hemorrhagic cyst was conformed in surgery
Fig. 2 MPNST with NF-1 in a 49-year-old male. A well-defined, ovoid mass lies in the subcutaneous tissue, which demonstrates hypo-intensity on
axial T1-weighted (B1) and obvious heterogeneous hyper-intensity on T2-weighted (B2) images. Perilesional edema and intratumoral lobulation
are noticeable on T2WI
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Surgical and pathological findings
Four superficial tumors and one retroperitoneal tumor
in MPNST group had grayish or yellowish appearance.
One facial mass became partially cystic and dark red
because of hemorrhage. Under microscope, they were
all composed of intersecting fascicles of spindle cells
alternated with hypocellular areas. In two NF-1 re-
lated tumors, there was more prominent mitosis and
atypia in nuclear as well as necrosis (Fig. 3 C4).
Immunohistochemical examinations were found posi-
tive for vimentin and S-100 protein. The retroperiton-
eal tumor in the upper abdomen was a lobulated
mass surrounded with capsule. Flesh, myxoid cystic
content was found in gross inspection. Adjacent spleen
and pancreas tail were involved. Pathological findings re-
vealed MPNST with glandular differentiation, immuno-
histochemical results showed positive reaction of CK,
NSE, and CD68.
Fig. 3 MPNST with NF-1 in a 47-year-old female. A well-defined, ovoid mass is located in the right pelvis wall, which demonstrates hypo-intensity
on axial T1-weighted (C1) and obvious heterogeneous hyper-intensity on T2-weighted (C2) images. On enhanced T1 images (C3), there is strong
enhancement in parts of the tumor with hypo-intense T2 signal, while moderate or slight enhancement in other parts. Note multiple subcutaneous
neurofibromas. Hematoxylin-eosin staining result (100 times) (C4) shows prominence in nuclear mitosis activities and atypia
Fig. 4 (D1) A huge, well-margined retroperitoneal MPNST is shown on enhanced CT scan, with feeding vessels inside. (D2) On the lower level, a
hypo-attenuated foci can be observed, which was turned out to be a myxoid cyst
Yu et al. World Journal of Surgical Oncology  (2016) 14:142 Page 5 of 8
Discussion
Clinical data
MPNST is a kind of rare, aggressive neurogenic tumor,
accounting for only 5–10 % of soft tissue sarcomas [7].
It usually originates from the peripheral nerves, and in
rare occasions, from malignant transformation of benign
neurogenic tumor. The most common anatomic sites in-
clude proximal portion of the upper extremities, lower
extremities and trunk. Redzepagic et al. [5] reported a
case in the breast, which is a rare location for MPNST.
Rafailidis et al. [6] believe that MPNST typically affects
major nerve trunks like the sciatic nerve, the brachial
plexus, and the sacral plexus. However, in our group,
except for two retroperitoneal tumors, all MPNSTs devel-
oped superficially and had no direct connection with these
major nerve trunks. MPNST usually affects patients in 20
to 50 years old, without gender predilection [6]. It occurs
more often in association with NF-1 and leads to poor
prognosis. Two MPNSTs in our group with history of
NF-1 were more aggressive, with histologically more
nuclear mitosis activities and obvious atypia.
Radiological features
Size
Probably due to rapid growth, average size of MPNST is
usually above 5 cm and larger than that of BPNST [8].
Boundary
MPNST can infiltrate into the surrounding soft tissue
and cause peritumoral edema, which makes the bound-
ary unclear (Fig. 2). Benign neurogenic tumor tends to
be well defined and usually surrounded with capsule.
However, some plexiform neurofibromas also have infil-
trative appearance. When grows deeply, MPNST may be
well margined. Two retroperitoneal MPNSTs in our
study were well defined because they were surrounded
with fat tissue, and capsule was founded in one abdom-
inal lesion in surgery, possibly formed by compression of
surrounding tissue in rapid growth. Ill-defined margin
and peritumoral edema can be a useful sign but lack of
specificity.
Relation with adjacent tissue
Spilt-fat sign is often seen in benign neurogenic tumor.
MPNSTs in our group grew in subcutaneous tissue or
retroperitoneal region, so this sign is irrelevant. Most of
BPNST in our group were eccentric to adjacent nerves.
Although developed in the peripheral nerve, contiguity
with adjacent nerves was not observed in most MPNST
cases. Perhaps they were originated from the minor
branches of the nerve, which cannot be observed clearly
in imaging and macro-examination. Li et al. [9] believed
that contiguity with a specific nerve may support the
diagnosis of a BPNST rather than a malignant one. This
result is partly in agreement with our study, but we be-
lieve this sign is largely dependent on the location of the
tumor.
Signal or density
On T1WI images, 18 BPNSTs showed inhomogeneous
signal because of enlarged vessels. Signals of MPNST
were relatively homogenous, only one tumor showed
mixed-intense signal (focal high signal) because of
hemorrhage. Matsumine et al. [10] thought that the
presence of high signal on T1WI is a diagnostic indica-
tor. Hemorrhage is also seen in schwannoma, so this
sign may be not so specific. On T2WI images, in BPNST
group, signals of 20 tumors were hyper-intense, and 2
tumors were mixed-intense because of enlarged vessels
and deposition of hemosiderin after hemorrhage. There
were different types of signal, including target sign, sin-
gle or multiple cystic appearance, and homogenous sig-
nal. MPNST usually shows inhomogeneous signal,
especially in the context of NF-1. This sign is in accord-
ance with its malignant nature and indicates a poor
prognosis. Two NF-1-associated MPNSTs in our study
had complex signal on T2WI and were histologically more
aggressive. Because there is only short-term follow-up
since surgery, the outcomes are still unknown.
Target sign (peripheral high signal and central low sig-
nal on T2WI) is a characteristic sign of neurogenic
tumor [9]. It is attributed to central fibrocollagenous tis-
sue and peripheral myxomatous tissue [10]. It is rarely
seen in MPNST. In our group, no typical target sign can
be found in MPNST. But in BPNST group, only five
cases showed this sign. So, we believe that target sign
plays a limited role in differential diagnosis. Demehri et al.
[11] studied 9 MPNSTs and 22 BPNSTs and found no
significant difference in the presence of a target sign be-
tween them.
Intratumoral lobulation can also be detected in
MPNST. It is considered to originate from a network-
like growth of plexiform neurofibromas involving mul-
tiple fascicles and/or branches of a nerve, leading to a
diffuse mass of thickened nerves [12]. In our group,
there were four cases of MPNST and two cases of
BPNST showing this sign (Fig. 2).
Enhancement
In contrast to central enhancement of BPNST, MPNST
often shows peripheral enhancement on contrast-
enhanced T1-weighted images [13]. In five BPNSTs with
target sign of our group, there was strong enhancement
in the center and slight enhancement in the peripheral
region, that is to say, opposite signal to T2WI. It can be
explained by more blood supply needed for tumor cells
in the centrally densed area. In MPNST group, there was
no such sign. Four MPNSTs enhanced significantly with
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foci lack of perfusion, which can be explained by cystic
change or necrosis (Fig. 1). There was a case of MPNST
with glandular differentiation in our group (Fig. 4),
which showed consistent enhancement with tumor ves-
sels inside. In surgery, cystic content was found. After a
careful review of the images, we can find a hypo-
attenuated area in tumor. Schwannoma can demonstrate
peripheral enhancement because of cystic change, but
rarely in neurofibroma. Wasa et al. [14] believed that
intratumoral cystic change can assist in the differenti-
ation of neurofibroma from MPNST. In our point of
view, there may be a cyst formation in MPNST with per-
ipheral enhancement, but the signal is complex on
T2WI because of hemorrhage. This is different from
hyper-intense signal in cystic formation. Peripheral en-
hancement with non-cystic appearance may be a valuable
sign of MPNST. There was remarkable heterogeneous en-
hancement in two NF-related MPNST cases (Fig. 3),
which can also be a sign of malignancy.
Brief introduction of previous studies
As for signs that are criminative between MPNST and
BPNST, there are different points of view (Table 3).
Chhabra et al. [4] laid a great importance on distinguish-
ing MPNST between NF-1 and non-NF-1 patient and
stressed that ill-defined margins and/or invasion of adja-
cent structures are highly specific for malignancy. Li
et al. [9] reviewed 16 schwannomas, 1 neurofibroma,
and 9 MPNSTs and draw a conclusion that larger size
and infiltrative margin can be suggestive of malignancy.
Matsumine et al. [10] analyzed data of neurofibroma
and MPNST in 37 NF-1 patients and concluded that
intratumoral lobulation and presence of high signal
on T1WI were indicators of MPNST. Demehri et al. [11]
studied 31 peripheral nerve sheath tumors, and hence,
reached a conclusion that average tumor diameter
and minimum ADC values are potentially important
parameters. Derlin et al. [13] studied 67 BPNSTs, 8
MPNSTs, and decided that intratumoral lobulation,
ill-defined margins, and irregular enhancement on T1WI
were significantly associated with MPNSTs. Matsumoto
et al.’s work [15] elaborated on dumbbell schwannomas
and MPNSTs and stressed the importance of large max-
imal diameter, irregularly lobulated shape, boundary in-
distinguishable from surrounding tissues, and osteolytic
bone destruction. Their studies are largely the same,
focusing on tumor size, boundary, and intratumoral
lobulation, which are lack of specificity. In a detailed study,
Wasa et al. [14] believed that two or more of four signs
(largest dimension, peripheral enhancement, perilesional
edema, and cystic lesion.) may support the diagnosis of
MPNST and stressed the meaning of peripheral en-
hancement. In our study, we made further investigation
and combined peripheral enhancement with character-
istic of signal.
Conclusions
MR imaging, as a noninvasive imaging technique, plays
an important role in diagnosis before surgery. MPNST
has diversity in imaging manifestations. Peripheral en-
hancement with non-cystic appearance and obvious het-
erogeneous enhancement may be valuable in diagnosis.
Besides that, we believe, several points could be helpful
to differentiate MPNST from BPNST: (1) over 5 cm in
size and ill-defined, (2) peritumoral edema, when located
superficially, (3) intratumoral lobulation, (4) absence of
target sign, and (5) bone destruction is an indicative
for malignancy. Except for the last sign, no single
sign is enough for diagnosis. A combination of two or
more of these features can facilitate us in early diag-
nosis and improve the prognosis, especially in patient
with NF-1.
This study had some limitations. As MPNST is rare,
only six cases were inrolled in the study, making the study
less persuasive. But after careful comparisons with benign
Table 3 Imaging findings supportive of MPNST based on studies of different authors
Matsumoto et al. Chao-siang Li et al. Matsumine et al. Wasa et al. Derlin et al. Demehri et al. Chhabra et al.
BPNST 15 17 18 20 67 22 35
MPNST 8 9 19 41 8 9 21
Irregular shape √ √
Large size √ √ √ √
Unclear margin √ √ √ √ √
Cystic change √
Intratumoral lobulation √ √ √




Yu et al. World Journal of Surgical Oncology  (2016) 14:142 Page 7 of 8
tumors and detailed review of literature, there is still
some meaning for diagnosis.
Ethics approval and consent for publication
Because this study involves no experiment, ethics ap-
proval is waived. Written informed consents were ob-
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